1. Home
  2. IGR vs REPL Comparison

IGR vs REPL Comparison

Compare IGR & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGR
  • REPL
  • Stock Information
  • Founded
  • IGR 2004
  • REPL 2015
  • Country
  • IGR United States
  • REPL United States
  • Employees
  • IGR N/A
  • REPL N/A
  • Industry
  • IGR Finance Companies
  • REPL Biotechnology: Pharmaceutical Preparations
  • Sector
  • IGR Finance
  • REPL Health Care
  • Exchange
  • IGR Nasdaq
  • REPL Nasdaq
  • Market Cap
  • IGR 776.6M
  • REPL 721.7M
  • IPO Year
  • IGR N/A
  • REPL 2018
  • Fundamental
  • Price
  • IGR $4.63
  • REPL $10.03
  • Analyst Decision
  • IGR
  • REPL Buy
  • Analyst Count
  • IGR 0
  • REPL 9
  • Target Price
  • IGR N/A
  • REPL $12.00
  • AVG Volume (30 Days)
  • IGR 747.7K
  • REPL 2.3M
  • Earning Date
  • IGR 01-01-0001
  • REPL 11-06-2025
  • Dividend Yield
  • IGR 13.93%
  • REPL N/A
  • EPS Growth
  • IGR N/A
  • REPL N/A
  • EPS
  • IGR N/A
  • REPL N/A
  • Revenue
  • IGR N/A
  • REPL N/A
  • Revenue This Year
  • IGR N/A
  • REPL N/A
  • Revenue Next Year
  • IGR N/A
  • REPL N/A
  • P/E Ratio
  • IGR N/A
  • REPL N/A
  • Revenue Growth
  • IGR N/A
  • REPL N/A
  • 52 Week Low
  • IGR $3.88
  • REPL $2.68
  • 52 Week High
  • IGR $5.70
  • REPL $14.80
  • Technical
  • Relative Strength Index (RSI)
  • IGR 36.92
  • REPL 70.49
  • Support Level
  • IGR $4.50
  • REPL $8.50
  • Resistance Level
  • IGR $4.70
  • REPL $9.63
  • Average True Range (ATR)
  • IGR 0.09
  • REPL 0.61
  • MACD
  • IGR -0.01
  • REPL -0.04
  • Stochastic Oscillator
  • IGR 31.76
  • REPL 95.59

About IGR CBRE Global Real Estate Income Fund of Beneficial Interest

CBRE Clarion Global Real Estate Income Fund is a United States-based diversified, closed-end management investment company. Its primary objective is high current income, and its secondary objective is capital appreciation. The fund invests a majority of its total assets in income-producing real estate securities, which includes common stocks, preferred securities, warrants, and convertible securities issued by real estate companies, such as real estate investment trusts. Under normal market conditions, it invests in real estate equity securities of companies domiciled predominantly in developed countries.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: